Mutation spectrum and haplotype study of mucopolysaccharidosis type IIIC patients reveal possible migration events and founder effects of HGSNAT mutations

Volume: 120, Issue: 1-2, Pages: S92 - S92
Published: Jan 1, 2017
Abstract
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a rare X-linked lysosomal storage disease caused by mutations of the gene encoding the lysosomal enzyme iduronate-2-sulfatase (IDS), the role of which is to hydrolytically remove O-linked sulfates from the two glycosaminoglycans (GAGs) heparan sulfate (HS) and dermatan sulfate (DS). HS and DS are linear, heterogeneous polysaccharides composed of repeating disaccharide subunits of...
Paper Details
Title
Mutation spectrum and haplotype study of mucopolysaccharidosis type IIIC patients reveal possible migration events and founder effects of HGSNAT mutations
Published Date
Jan 1, 2017
Volume
120
Issue
1-2
Pages
S92 - S92
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.